Find the perfect CRO

Whatever your needs, you'll find the perfect partner. BeCRO members share common values, amongst them high quality standards, responsiveness and essential human trust.

Spotlight

On 25th March, FAMHP published Addendum to the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic

Please note that this document is to be read in conjunction with the latest version of the
European guidance and that the national guidance provides some more detailed
clarifications and additional topics of interest. This text was written by the FAMHP, the
Clinical Trial College and the Belgian Association of Research Ethics Committees (BAREC).
The information in this guidance can be applied from the moment of publication until
there is a new version.
The situation is evolving rapidly and further updates to this
guidance are therefore expected.

https://www.fagg.be/sites/default/files/content/guidance_on_the_management_of_clinical_trials_during_the_covid-19_coronavirus_pandemic.pdf

WHY BECOME A BECRO MEMBER?

Our latest news

Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials

On 25th March, EMA issued a draft guidance for consultation with deadline for comments on 25th April. https://www.ema.europa.eu/en/documents/scientific-guideline/points-consider-implications-coronavirus-disease-covid-19-methodological-aspects-ongoing-clinical_en.pdf

Read More "Draft points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials"

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

On 20th of March, The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic. The impact of the pandemic on European health systems and more broadly […]

Read More "Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic"

EMA/CHMP statement on Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments

Dear Industry Stakeholders, The EMA’s Human Medicines Committee (CHMP) has published a statement urging the EU research community to prioritise large randomised controlled studies because they are most likely to generate the conclusive evidence needed to enable rapid development and approval of potential treatments of CIVID-19. The statement promotes a harmonised approach to data collection […]

Read More "EMA/CHMP statement on Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments"

Need more information ?

BECRO

PLACE MARCEL BROODTHAERS PLEIN, 8 BOX 5
B-1060 BRUSSELS / BELGIUM
PHONE: +32 (0)2 892 40 00
E-MAIL: INFO@BECRO.BE

© 2018 BECRO – ALL RIGHTS RESERVED

Octopix + WordPress = ♥ | Design by Simplexity